CHM

0.00%

1.5¢ chimeric therapeutics limited

Finally we see it the same way, Valueadd and Steini on the same...

First 18 Last

Share
Profile

Follow
Steini

12,562 Posts.

3815

31/07/24

15:37

Post #: 75007694
Share

Originally posted by valueadd: ↑

There is potentially quite a huge rabbit in the hat to pull out .

Worth looking at a few of the recent vids with the new COO & also worth checking out her background

As well worth trying to get a bit of an understanding as to exactly what CHM are doing - its pure R& D at the moment - but in a field where some of the valuations of similar /like type of treatments and therapies have attracted extremely high valuations

The stock originally listed at 20 cents a share ..... a few years back .... they have raised capital ....a couple of times ..... like a number of companies like this they are pretty well shunned by the market .

A lot more to the story ....and worth understanding

The board has recently made provision to expand the issue X approx 100% --which will take SoI to approx 1.6-1.7 Bill .. ... I suspect IF all tnse shares are taken up they will be a major corner stone investor .... and probably wont be at much of a premium to the current pricing range ...unless there is some brilliant salesmanship done by the current board/ seniour managements . Probably doesn't matter much in the long run if the stock is taken up at current prices , a bit less or a bit more ..... so long its take up bu a player in the field .

Just so long as there is fuel in the tank ....for the next year or so

IF the current line of R& D produce the data many think they will ..... then iis not beyond the realm of reason to put a price tag on developing IP asset way way higher ....could even be 10 20 times who knows .

IF it all sounds like BS ... thats OK & maybe not for you

Dont bet the house ..... but a garage could well be an interesting outcome .

cheers

Expand

Finally we see it the same way, Valueadd and Steini on the same page - Hallelujah! What can go wrong from here? LOL

GLTA

CHM Price at posting: 1.9¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

As Nvidia cools, we're looking to Aussie AI

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

There are more pages in this discussion • 55 more messages in this thread...

First 18 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.5¢		Change 0.000(0.00%)		Mkt cap ! $13.40M

Open	High	Low	Value	Volume
1.5¢	1.5¢	1.5¢	$7.588K	505.8K

Buyers (Bids)

No.	Vol.	Price($)
21	1919600	1.5¢

Sellers (Offers)

Price($)	Vol.	No.
1.6¢	28828	1

View Market Depth

No.	Vol.	Price($)
21	1919600	0.015
7	912261	0.014
4	710769	0.013
3	83416	0.012
4	279041	0.011

Price($)	Vol.	No.
0.016	28828	1
0.017	617827	2
0.018	510000	4
0.019	1948702	6
0.020	1223093	5

Last trade - 16.10pm 06/09/2024 (20 minute delay)

CHM (ASX) Chart

Finally we see it the same way, Valueadd and Steini on the same...

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

As Nvidia cools, we're looking to Aussie AI

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Shekel Brainweigh investor presentation webinar – the future of retail automation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Finally we see it the same way, Valueadd and Steini on the same...

Top Stories

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

As Nvidia cools, we're looking to Aussie AI

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Shekel Brainweigh investor presentation webinar – the future of retail automation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News